Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study.

Visco, Carlo

Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study. [electronic resource] - Blood 11 2019 - 1708-1711 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1528-0020

10.1182/blood.2019001617 doi


Adult
Aged
Aged, 80 and over
Benzoates--adverse effects
Blood Platelets--drug effects
Chronic Disease
Female
Humans
Hydrazines--adverse effects
Lymphoproliferative Disorders--complications
Male
Middle Aged
Prospective Studies
Purpura, Thrombocytopenic, Idiopathic--complications
Pyrazoles--adverse effects